Dark Light

Zelira’s share price has experienced a significant surge following a study revealing that their cannabinoid drug has surpassed a multibillion-dollar product by Pfizer in terms of performance.

Zelira Therapeutics, a company listed on the Australian Securities Exchange (ASX), witnessed a remarkable 230% surge in its share price. This surge followed the release of study results demonstrating that

Read More
Leave a comment